Mabion S.A.

Poland · Pharmaceuticals

Mabion S.A. is a biotechnology company based in Konstantynów Łódzki, Poland, founded in 2007. It operates as a Contract Development and Manufacturing Organization (CDMO) specializing in biologics. The company provides comprehensive services for biopharmaceutical development and production, including the development and manufacturing of biopharmaceutical products, analytical method development, and support for clinical trial material production. Mabion collaborates with various pharmaceutical and biotech companies, including Novalgen, WPD Pharmaceuticals, Sartorius, IBMP, and Novavax. These partnerships highlight its strong presence in the European biopharma sector. The company is publicly traded on the Warsaw Stock Exchange under the ticker MAB and emphasizes high production and analytical standards typical of European CDMOs. Mabion is focused on expanding its business development efforts and maintaining a solid financial position.